Get your science and technology news from Saint Vincent and the Grenadines

Provided by AGP

Tech News St. Vincent & Grenadines
Got News to Share?
Got News to Share? globe Explore more publications!

Tech News St. Vincent & Grenadines: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 21, 2026

SportsReflector Debuts First Mobile AI Sports & Fitness Coach With Real-Time Video Analysis, Live AR, and Remote Coaching
Apr. 21, 2026

SportsReflector Debuts First Mobile AI Sports & Fitness Coach With Real-Time Video Analysis, Live AR, and Remote Coaching

Indeterminate GlobeNewswire
Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors
Apr. 21, 2026

Trethera Announces Appointment of M. Andrew (“Drew”) Woodmansee to Board of Directors

Indeterminate GlobeNewswire
Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting
Apr. 21, 2026

Black Diamond Therapeutics Announces Oral Presentation of Silevertinib Phase 2 Data in Frontline EGFRm NSCLC Patients at the 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
Apr. 21, 2026

ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026

Indeterminate GlobeNewswire
Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial
Apr. 21, 2026

Cemdisiran, Dosed Subcutaneously Every 12 Weeks, Demonstrates Rapid, Deep and Sustained Disease Control in Generalized Myasthenia Gravis (gMG) Phase 3 Trial

Indeterminate GlobeNewswire
Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer
Apr. 21, 2026

Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer

Indeterminate GlobeNewswire
MazeBolt Continuously Validates DDoS Protection Against AI-driven DDoS Threats, for Leading Greek Financial Institution
Apr. 21, 2026

MazeBolt Continuously Validates DDoS Protection Against AI-driven DDoS Threats, for Leading Greek Financial Institution

Indeterminate GlobeNewswire
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
Apr. 21, 2026

Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting

Indeterminate GlobeNewswire
The Ungoverned Workforce: Cybersecurity Insiders Finds 92% Lack Visibility Into AI Identities
Apr. 21, 2026

The Ungoverned Workforce: Cybersecurity Insiders Finds 92% Lack Visibility Into AI Identities

Indeterminate GlobeNewswire
DocHub Expands PDF Editing Capabilities With The New Edit Text Feature
Apr. 21, 2026

DocHub Expands PDF Editing Capabilities With The New Edit Text Feature

Indeterminate GlobeNewswire
NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
Apr. 21, 2026

NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026

Indeterminate GlobeNewswire
Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting
Apr. 21, 2026

Aprea Therapeutics to Provide Clinical Update on ACESOT-1051 Phase 1 Trial Evaluating WEE1 Inhibitor, APR-1051, at ASCO 2026 Annual Meeting

Indeterminate GlobeNewswire
IP Strategy Announces Reverse Stock Split
Apr. 21, 2026

IP Strategy Announces Reverse Stock Split

Indeterminate GlobeNewswire
Forge Nano, U.S. Advanced Manufacturing Leader for AI-Era Chips and Defense Batteries, to List on NASDAQ through Merger with Archimedes Tech SPAC Partners II Co.
Apr. 21, 2026

Forge Nano, U.S. Advanced Manufacturing Leader for AI-Era Chips and Defense Batteries, to List on NASDAQ through Merger with Archimedes Tech SPAC Partners II Co.

Indeterminate GlobeNewswire
ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026
Apr. 21, 2026

ImPact Biotech Announces Upcoming Data Presentations for Padeliporfin VTP at AUA and ASCO 2026

Indeterminate GlobeNewswire
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026
Apr. 21, 2026

Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026

Indeterminate GlobeNewswire
Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026
Apr. 21, 2026

Cardiff Oncology to Present Updated Phase 2 Data of Onvansertib in First-Line RAS-Mutated mCRC in a Rapid Oral Session at ASCO 2026

Indeterminate GlobeNewswire
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
Apr. 21, 2026

Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026
Apr. 21, 2026

Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026

Indeterminate GlobeNewswire
Progress Software Releases 2025 Corporate Social Responsibility Report, Underscoring Global Commitment to Giving Back
Apr. 21, 2026

Progress Software Releases 2025 Corporate Social Responsibility Report, Underscoring Global Commitment to Giving Back

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
LinkedIn Facebook

Sign up for:

Tech News St. Vincent & Grenadines

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.